Insulin (bodybuilding use)

As a medicine, exogenous insulin is indispensable and unambiguously beneficial: it is the foundational, life-saving treatment for type 1 diabetes and an important therapy in type 2 — that approved use is real, evidence-based, and not in dispute.

This entry is about a completely different, illicit activity: the off-label use of injected insulin by bodybuilders and strength athletes as a so-called 'anabolic' for muscle growth and 'nutrient partitioning.' The physiological rationale is genuine but narrow.

Classic human metabolic work (Gelfand and Barrett, forearm-perfusion studies) showed that raising insulin to physiologic levels shifts muscle into net positive protein balance — but it does so almost entirely by INHIBITING muscle-protein BREAKDOWN, not by stimulating new protein synthesis.

The most rigorous synthesis of this literature — a systematic review and meta-analysis of insulin-infusion studies (Abdulla 2016) — is blunt about this: across 25 studies, insulin did NOT significantly increase muscle-protein synthesis; it significantly reduced breakdown, improving net balance, but its effect on synthesis is permissive and depends on adequate amino-acid availability.

In plain terms, in a healthy, well-fed athlete whose own pancreas already keeps insulin in the optimal range, injecting more insulin has no demonstrated power to build additional muscle.

There is NO randomized controlled trial — none — showing that exogenous insulin increases muscle mass, strength, or athletic performance in healthy non-diabetic people.

The 'anabolic' reputation in gym culture rests on theory, anecdote, and the visual 'fullness' of glycogen and water loading, not on controlled evidence of real hypertrophy or performance gain. Against that absent benefit sits an extreme, well-documented danger.

In someone whose glucose regulation is normal, an injection of exogenous insulin can drive blood glucose dangerously low; because insulin is invisible to standard anti-doping tests and is cheap and accessible, it has become a recurring cause of severe hypoglycemia in the bodybuilding community.

The case literature is grim and consistent: bodybuilders presenting in hypoglycemic coma, with seizures, requiring repeated/continuous intravenous glucose and intensive-care support — and surreptitious insulin use is now a recognized cause of unexplained coma in young, otherwise-healthy strength athletes (Evans and Lynch's 'Insulin as a drug of abuse in body building'; Heidet 2019; Konrad 1998).

Severe hypoglycemia can cause permanent brain injury and death; the margin for error is small and the dose-response unforgiving, especially when stacked with growth hormone, post-workout carbohydrate timing, or fasting.

Beyond hypoglycemia, chronic supraphysiologic insulin promotes fat storage (the opposite of the lean look it is taken for) and, with other doping agents, contributes to the broad metabolic harms documented for performance-enhancing drug misuse.

The score reflects this split honestly: a real but narrow anti-catabolic physiology, NO controlled evidence of any muscle or performance benefit in healthy athletes, and a documented risk of lethal hypoglycemia — a low-scoring, gated, harm-reduction entry.

Insulin's legitimate role is treating diabetes under medical supervision; using it to build muscle is illicit, unproven, and can kill. It is a prescription drug, not a dietary supplement, and there is no longevity rationale here.